Virginia Retirement Systems’s Apellis Pharmaceuticals APLS Stock Holding History

Virginia Retirement Systems’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$612K	Sell	24,365 -1,100	-4%	-$25.8K	﹤0.01%	711
2025 Q3	$576K	Sell	25,465 -2,200	-8%	-$51.3K	﹤0.01%	720
2025 Q2	$479K	Buy	27,665 +3,000	+12%	+$55.5K	﹤0.01%	759
2025 Q1	$539K	Buy	+24,665	New	+$681K	﹤0.01%	729
2023 Q3	$373K	Buy	9,800 +3,000	+44%	+$132K	﹤0.01%	771
2023 Q2	$619K	Sell	6,800 -4,000	-37%	-$345K	0.01%	670
2023 Q1	$712K	Sell	10,800 -4,200	-28%	-$242K	0.01%	639
2022 Q4	$776K	Sell	15,000 -1,000	-6%	-$53K	0.01%	687
2022 Q3	$1.09M	Buy	+16,000	New	+$947K	0.01%	548
2022 Q1	$305K	Buy	6,000 +400	+7%	+$17.7K	﹤0.01%	970
2021 Q4	$265	Buy	+5,600	New	+$220K	﹤0.01%	1007

Other funds holding APLS

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Virginia Retirement Systems's APLS Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Apellis Pharmaceuticals (APLS) stake by 4.3% in Q4 2025, selling an estimated $25.8K and leaving 24,365 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Virginia Retirement Systems first reported a position in APLS in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.09M in Q3 2022. 279 funds tracked by Wall St. Rank hold APLS as of Q4 2025.

Virginia Retirement Systems held 24,365 shares of Apellis Pharmaceuticals worth $612K as of Q4 2025.
Virginia Retirement Systems sold 1,100 Apellis Pharmaceuticals shares in Q4 2025, an estimated $25.8K.
Apellis Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #711 holding.
Virginia Retirement Systems first reported a position in Apellis Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
Virginia Retirement Systems's Apellis Pharmaceuticals position peaked at $1.09M in Q3 2022.
279 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.